Search for: "Mylan Inc."
Results 461 - 480
of 674
Sorted by Relevance
|
Sort by Date
6 Oct 2015, 9:53 am
Sandoz Inc. [read post]
7 May 2012, 5:00 am
Mylan Pharmaceuticals, Inc., ___ F. [read post]
13 Sep 2013, 6:49 pm
USA, Inc. v. [read post]
15 Aug 2012, 11:02 am
District Court for the District of Columbia by Watson Laboratories, Inc. [read post]
7 Sep 2010, 6:10 pm
Genpharm Inc. et al. [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
19 Aug 2019, 11:39 am
Mylan Laboratories Ltd., 757 Fed. [read post]
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
29 May 2024, 11:27 am
Mylan Pharmaceuticals Inc., Case No. 1:22-CV61 (KLEEH) (N.D. [read post]
1 Mar 2011, 8:38 pm
Roche Molecular Systems, Inc. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog) Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on… [read post]
19 Dec 2017, 3:13 pm
Mylan Labs., Inc., 464F.3d 1286, 1289 (Fed. [read post]
12 Apr 2017, 9:52 am
(collectively, Novartis).The Board instituted IPRs on all claims of the ’283 patentbased on petitions filed by Torrent PharmaceuticalsLimited, Apotex, Inc. and Mylan Pharmaceuticals Inc. [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
23 Mar 2018, 10:54 am
Mylan Inc. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
23 Mar 2018, 10:54 am
Mylan Inc. [read post]
